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Abstract: Human parvovirus B19 (B19V) traffics to the cell nucleus where it delivers the genome
for replication. The intracellular compartment where uncoating takes place, the required capsid
structural rearrangements and the cellular factors involved remain unknown. We explored conditions
that trigger uncoating in vitro and found that prolonged exposure of capsids to chelating agents or
to buffers with chelating properties induced a structural rearrangement at 4 ◦C resulting in capsids
with lower density. These lighter particles remained intact but were unstable and short exposure
to 37 ◦C or to a freeze-thaw cycle was sufficient to trigger DNA externalization without capsid
disassembly. The rearrangement was not observed in the absence of chelating activity or in the
presence of MgCl2 or CaCl2, suggesting that depletion of capsid-associated divalent cations facilitates
uncoating. The presence of assembled capsids with externalized DNA was also detected during
B19V entry in UT7/Epo cells. Following endosomal escape and prior to nuclear entry, a significant
proportion of the incoming capsids rearranged and externalized the viral genome without capsid
disassembly. The incoming capsids with accessible genomes accumulated in the nuclear fraction,
a process that was prevented when endosomal escape or dynein function was disrupted. In their
uncoated conformation, capsids immunoprecipitated from cytoplasmic or from nuclear fractions
supported in vitro complementary-strand synthesis at 37 ◦C. This study reveals an uncoating strategy
of B19V based on a limited capsid rearrangement prior to nuclear entry, a process that can be mimicked
in vitro by depletion of divalent cations.
Keywords: B19V; parvovirus; uncoating; divalent cations; capsid stability; genome externalization;
trafficking; nuclear targeting
1. Introduction
Human parvovirus B19 (B19V) commonly causes a mild childhood disease known as erythema
infectiosum, or fifth disease [1]. In adults, the virus can cause a range of clinical manifestations, and
infection during pregnancy may result in hydrops fetalis and foetal death [2]. B19V is transmitted
principally through the respiratory route and targets the bone marrow where it infects and kills
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erythroblast precursors. The single-stranded DNA genome of B19V is packaged into a small,
nonenveloped, T = 1 icosahedral capsid consisting of 60 structural subunits, of which approximately
95% are VP2 (58 kDa) and 5% are VP1 (83 kDa). VP1 and VP2 are identical except for 227 additional
amino acids at the VP1 N-terminal region, the so-called VP1 “unique region” (VP1u) [3].
Viral capsids assemble as highly stable structures to retain and protect the genome during their
extracellular phase. However, they also have a built-in ability for disassembly when entering a new
host cell. These apparently contradictory functions are possible because the robust protective capsids
are metastable. They are conceived to rearrange upon specific cellular cues, adopting a sequence of
structural configurations in a stepwise manner. Those configurations enable the intracellular transport
of capsids and the release of the genome in the appropriate cell compartment for replication [4].
Viral capsids have evolved various strategies to balance their stability outside of the cell against
their capacity to disassemble inside the cell. The switch between capsid stability and instability is
mediated by specific cellular cues. Cellular receptors, attachment factors, proteases, kinases, ubiquitin
or cellular motors among others facilitate virus uncoating by direct interaction with the capsid.
A particular intracellular environment, such as the low endosomal pH, reducing conditions or low
calcium concentrations may also provide cues for uncoating [5–7]. During cell entry, parvoviruses
traffic through various cellular compartments before they reach the cell nucleus where the viral genome
is delivered for replication [8]. The intracellular compartment where uncoating takes place, the required
capsid structural rearrangements and the cellular cues involved in the process are poorly understood.
Similar to other parvoviruses, B19V enters the cell through clathrin-mediated endocytosis [9].
Although the endocytic elements involved and the sites of escape into the cytosol may vary among
parvovirus species and cells [10,11], parvoviruses depend on the endosomal acidification, notably
to trigger the exposure of VP1u and its constitutive phospholipase A2 (PLA2) activity, required to
promote endosomal escape [12]. In contrast to other parvoviruses, B19V does not require endosomal
acidification for VP1u exposure, which occurs already at the cell surface to promote virus uptake [13–16].
However, low pH is still required for efficient endosomal escape. Accordingly, bafilomycin A1, which
elevates the endosomal pH, but without compromising the integrity of endosomes, blocks the virus
inside endocytic vesicles. In contrast, chloroquine, which induces endosomal vesicle enlargement and
weakening, preventing their fusion to lysosomes [17], assists B19V infection by promoting endosomal
escape [9]. The steps following the escape from endosomes are less well understood. Several studies
have shown that cytoplasmic trafficking of parvovirus capsids is a microtubule-dependent process
using cellular dynein as a motor protein [18,19]. However, other studies have shown that intracellular
trafficking does not depend on dynein function or an intact microtubule network [20,21]. It has been
proposed that parvoviruses enter the nucleus through the nuclear pore complex (NPC) via nuclear
localization signals in the exposed VP1u [22–26]. A radically different mechanism has been suggested,
which involves translocation of the capsids through discrete transient nuclear envelope (NE) breaks
involving cell host caspases [27,28]. Through the NPC or through NE breaks, parvoviruses are small
enough to enter the nucleus without capsid disassembly. However, it remains a matter of debate
whether the infectious nuclear entry may still involve or not a disassembly process. Adeno-associated
virus (AAV) infectivity can be blocked by injecting a neutralizing antibody against intact capsids into
the nucleus [23]. However, other authors have shown that viruses enter the nucleus after partial or
total disassembly in the cytosol or NPC [29].
A narrow channel at each five-fold vertex connecting with the interior of the particle is a common
parvovirus structural feature and has been implicated in genome externalization and packaging [30–34].
In B19V capsids, the external end of the channel is closed, however, the presence of three consecutive
glycine residues may provide the required flexibility to open the channel to allow the release of
the viral DNA [35]. In agreement with this concept, in vitro studies have shown that parvovirus
capsid disassembly is not required to externalize the viral genome [36–41]. Studies to understand
the conditions required for DNA release at physiological conditions have shown that depletion of
capsid-associated divalent cations in minute virus of mice (MVM) rendered the virions unstable and
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exposure to 37 ◦C was sufficient to trigger the externalization of the genome, which remained associated
with the assembled capsid. The pressure of the encapsidated full-length viral DNA was important
to promote the externalization at physiological temperatures [42]. A similar phenomenon was also
observed in AAV, where the stability of virions containing full-length genomes required the presence
of divalent cations in contrast to those containing subgenomic DNA [37,40].
Although the in vitro studies provide useful information, it remains uncertain whether the
observed genome externalization without capsid disassembly can also occur in vivo during the process
of virus entry. With the aim to gain insight into the mechanisms of B19V uncoating, conditions
triggering viral DNA externalization at physiological temperatures were explored. To this end, virion
density, capsid integrity and DNA accessibility were thoroughly examined in vitro upon exposure of
virions to different conditions. Capsid rearrangements and uncoating were also followed in vivo during
the process of cell entry. Viruses associated to cytoplasmic or to nuclear fractions were characterized
at increasing times post-internalization by antibodies targeting capsid epitopes and phosphorylated
amino acids. Additionally, the accessibility of the viral DNA was examined by immunoprecipitation
and nuclease digestion and its suitability as a template for complementary-strand synthesis was
evaluated by a primer hybridization and extension assay.
2. Materials and Methods
2.1. Cells and Viruses
The human megakaryoblastoid cell line UT7/Epo was cultured in Eagle’s minimal essential medium
(MEM), supplemented with 5% fetal calf serum (FCS), 2 U/mL recombinant human erythropoietin
(Epo) and penicillin/streptomycin. A B19V-infected plasma sample with a high viral load (genotype 1)
was obtained from CSL Behring (Bern, Switzerland). The virus was concentrated by ultracentrifugation
through 20% sucrose cushion. The virus pellet was resuspended in MEM, 20 mM HEPES or PBS and
immediately used or stored at 4 ◦C.
2.2. Antibodies and Chemicals
The monoclonal antibody 860-55D (referred as Caps) was obtained from Mikrogen (Neuried,
Germany). The antibody recognizes a conformational epitope expanding three neighboring VP2
molecules related by a five-fold and by a three-fold axis [43], and does not recognize disassembled
capsids. This antibody was obtained from an infected healthy adult and is neutralizing [44].
The polyclonal rabbit antibody against the PLA2 region (referred as PLA2) was obtained as previously
described [13]. The anti-phosphotyrosine mAb (clone 4G10), lambda phosphatase and the cytoplasmic
dynein inhibitor ciliobrevin D (CbD) were purchased from EMD Millipore (Billerica, MA, USA).
Anti-lamin A/C and anti-SERCA2 ATPase antibodies were obtained from Abcam (Cambridge, MA,
USA). Bafilomycin A1 (BafA1) and chloroquine, were purchased from Sigma (St. Louis, MO, USA).
CbD and BafA1 were solved in DMSO and CQ was solved in water.
2.3. Quantitative PCR
Amplification of B19V DNA and real-time detection of PCR products were performed
using a CFX96 Real Time Detection System (Bio-Rad, Hercules, CA, USA). Quantitative PCR
(qPCR) was performed using the iTaqTM SYBR® Green Supermix kit (Bio-Rad) following the
manufacturer’s instructions. Primers used for B19V DNA amplification were as follows: B19V-forward,
5′-GGGCAGCCATTTTAAGTGTTT-3′; and B19V-reverse, 5′-GCACCACCAGTTATCGTTAGC-3′.
Plasmids containing the complete genome of B19V were used at 10-fold dilutions as external standards.
2.4. Iodixanol Density Gradient Ultracentrifugation
The virus suspension was applied onto an iodixanol gradient containing 1.5 mL 55%, 2 mL 45%, 2
mL 40%, 2 mL 35% and 1.5 mL 15% iodixanol solution in 20 mM HEPES. The virus suspension was
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adjusted to 2 mL with the corresponding buffer and centrifuged at 35,000 rpm for 18 h at 18 ◦C in a
swinging bucket rotor Beckman SW41Ti. After the centrifugation, 0.5 mL fractions were collected
from the top. The refractive index was determined for each fraction and the presence of the virus was
determined by dot-blot and qPCR.
2.5. Transmission Electron Microscopy
Purified B19V was resuspended in PBS alone or PBS supplemented with 1 mM MgCl2 and stored
at 4 ◦C for one month. Following a freeze/thaw cycle, 3 µL of each sample was applied to a freshly
glow-discharged continuous carbon grid from Electron Microscopy Sciences (Hatfield, PA, USA),
washed three times with dH2O, and stained with 3 µL 1% (w/v) phosphotungstic acid. CCD images
were acquired using a JEOL JEM 1200 EXII transmission electron microscope (Peabody, MA, USA) at
80 kV accelerating voltage, at 10,000× and 30,000×magnification.
2.6. Nuclease Assay
The presence of accessible DNA from the different virus samples was analysed by treatments
with DNase I (Sigma). DNase I digestion was performed at 37 ◦C for 1 h in a buffer containing 40 mM
Tris-HCl, pH7.9, 10 mM NaCl, 6 mM MgCl2 and 1 mM CaCl2. In order to test the DNase I activity, B19
viral particles were heated at 60 ◦C or 80 ◦C for 5 min. Native untreated virions served as controls.
To stop the reaction, the viral DNA was extracted with the DNeasy blood and tissue kit (Qiagen, Venlo,
Netherlands) and quantified as specified above.
2.7. Isolation of Cytoplasmic and Nuclear Fractions from Infected Cells
UT7/Epo cells (5 × 105) were incubated with B19V (2 × 104 virions per cell) for 1 h at 4 ◦C. The cells
were subsequently washed four times at 4 ◦C with PBS, resuspended in MEM and further incubated
at 37 ◦C to allow virus internalization. At increasing times post-internalization (pi), cytoplasmic or
nuclear fractions were prepared. For cytoplasmic purification without nuclear contamination, cells
were lysed in NP40 buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40) supplemented with a protease
inhibitor cocktail (Complete Mini; Roche, Basel, Switzerland). After incubation on ice for 30 min,
the cells were vortexed for 20 s and further incubated for 15 min on ice. Nuclei and cell debris were
removed by centrifugation at 14,000× g for 10 min at 4 ◦C. The absence of nuclear contamination was
determined by quantification of the human β-actin gene by qPCR.
For the isolation of nuclei, the cells were washed twice with ice-cold PBS and the pellets were
resuspended in 100 µL EZ buffer (Sigma) and the volume completed to 1 mL with additional EZ
buffer. The samples were vortexed and kept on ice for 5 min, then pelleted at 500× g for 5 min at 4 ◦C.
This step was repeated once. Pellets were then resuspended in 500 µL EZ buffer containing 0.25 M
sucrose and layered on top of 500 µL EZ buffer containing 0.5 M sucrose. The nuclei were collected
by centrifugation at 500× g for 10 min at 4 ◦C, washed with 1 mL EZ buffer and resuspended in the
desired buffer. The integrity of the isolated nuclei was assessed via light microscopy after trypan
blue staining. The purity of the nuclei and the absence of cytoplasmic contamination were examined
with antibodies against lamin A/C (marker for nuclear inner membrane), SERCA2 ATPase (marker
for endoplasmic reticulum), and GAPDH (cytoplasmic marker). For immunoprecipitation, the nuclear
pellets were resuspended in RIPA lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS), supplemented with protease inhibitor cocktail (Complete Mini;
Roche). The samples were incubated on ice for 20 min, vortexed for 20 s and further incubated for
15 min on ice. Nuclear debris was removed by centrifugation at 14,000× g for 10 min at 4 ◦C.
2.8. Immunoprecipitation
UT7/Epo cells were infected with B19V, as described above. At different times pi, viral particles
were immunoprecipitated from cytoplasmic or from nuclear fractions with a B19V specific antibody
against intact capsids (860-55D; Caps) or with an antibody against the PLA2 region in VP1u (PLA2).
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For immunoprecipitation of phosphorylated capsids, an antibody against phosphorylated tyrosine
was used (pTyr). After overnight incubation with 20 µL protein G agarose beads in LoBind tubes
(Eppendorf, Hamburg, Germany) at 4 ◦C, the beads were washed four times (three times with PBSA-1%
bovine serum albumin and once with PBS) and resuspended in protein loading buffer to analyse the
immunoprecipitated capsids by Western blotting or in PBS to quantify the viral DNA by qPCR. Total
DNA was extracted using the DNeasy blood and tissue kit (Qiagen) and quantified as specified above.
The immunoprecipitated capsids were also used for complementary-strand synthesis, as specified
below. The antibody 860-55D (Caps) was also used in immunoprecipitation experiments and dot-blot
assays to test the integrity of the capsids.
2.9. Infectivity Assay
Virus infectivity was examined by quantification of NS1 mRNA. Cells were transferred 24 h pi to
RNase-free tubes (Safe-Lock Tubes 1.5 mL, Eppendorf Biopur®) and pelleted. The pellet was washed
twice with PBS and stored at −20 ◦C until use. Total poly-A-mRNA was isolated with a Dynabeads
mRNA direct kit (Invitrogen). Following reverse transcription, cDNA was quantified by using iTaqTM
Universal SYBR® Green One-Step reagent kit (Bio-Rad, Hercules, CA, USA). Primers were chosen
to amplify a 133 nt-long NS1 cDNA fragment: NS1 forward (5’-GGGGCAGCATGTGTTAAAG-3’
(nucleotide 1017–1035) and NS1 reverse (5’-CCATGCCATATACTGGAACACT-3’ (nucleotide
1129–1150).
2.10. Complementary-Strand Synthesis
The presence of externalized DNA from the immunoprecipitated capsids and its suitability as a
template for initiation of DNA synthesis was examined by a primer hybridization and extension reaction
as previously described [38]. Briefly, primers consisting of a 3’ virus-specific and a 5’ virus-unrelated
sequence were used. The hybridization reaction was performed in 40 µL volumes containing 20 µL of
immunoprecipitated virus bound to protein G beads, 4 µL 5× hybridization buffer (40 mM Tris-HCl,
pH 7.5, 20 mM MgCl2 and 50 mM NaCl) and 2 µL primer (0.5 pmol), at 37 ◦C for 15 min. The hybridized
primer was extended by adding 2 µL DTT (100 mM), 2 µL dNTPs (200 µM each) and 4 µL (3.25 U)
of T7 DNA polymerase (Sequenase; USB, Cleveland, OH, USA) and incubated at 37 ◦C for 15 min
or 0 min (negative control). The reaction was stopped, and DNA was purified by using the Wizard®
SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA). The primer-extended DNA was
amplified by PCR as previously described [38] and the amplicons were separated by electrophoresis
and visualized by staining with GelRed (Biotium, Hayward, CA, USA).
3. Results
3.1. Depletion of Capsid-Associated Divalent Cations Destabilizes the B19V Capsid
Iodixanol density gradient ultracentrifugation and qPCR were used to detect and to quantify
changes in B19V capsid density. The density of native B19V from infected human plasma was compared
to the virus pelleted through a 20% sucrose cushion and resuspended in PBS. Native capsids in human
plasma and in PBS peaked at 1.22 g/mL, representing the density of intact native capsids (Figure 1A,B).
A dot-blot confirmed the presence of capsids in the same fractions as the viral DNA (Figure 1C).
Virus in PBS and exposed to 60 ◦C or 80 ◦C for 5 min resulted in a density shift to 1.09 g/mL, which
corresponds to free viral DNA (Figure 1D,E).
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Figure 1. Buoyant density of native B19V from infected plasma or purified and resuspended in PBS.
ractions from iodixa ol density gradient ultracentrifugation were collected and quantified by q CR.
(A) De sity of B19V from infec ed human plasma. (B) Density of B19V purified from in ected plasma
by ultracentrifugation through 20% sucrose cushion and resuspended in PBS. (C) Detection of B19V
capsids by dot-blot from density fractions of B19V in PBS. The correspo ding fractions are indicated
( –e). (D) Density of B19V treated at 60 ◦C for 5 min. (E) Density of B19V treated at 80 ◦C for 5 min.
The density of B19V resuspended in MEM, HEPES and PBS and stored for a period of four weeks
at 4 ◦C (prolonged exposure) was compared. While the virus density in MEM and HEPES did not
change (1.22 g/mL), prolonged exposure to PBS induced a structural rearrangement resulting in capsids
with lower density (1.20 g/mL) (Figure 2A). We next analysed the stability of B19V after prolonged
exposure (four weeks at 4 ◦C) to the different buffers followed by a single freeze/thaw cycle. While the
virus in MEM did not change, the virus in HEPES peaked at a similar density as the virus that was
exposed to PBS for a prolonged time at 4 ◦C (1.19 g/mL). In contrast, a major density shift was observed
after a freeze/thaw cycle in the virus exposed to PBS (1.11 g/mL). This shift was fully prevented when
PBS as supplemented with 1 mM of MgCl2 or 1 mM CaCl2 (1.23 g/mL), suggesting that divalent
cations have a stabilizing effect on the virion (Figure 2B). To further study the influence of divalent
cations, the effect of the chelating agents EDTA and EGTA on the virus density was analysed. Prolonged
exposure (four weeks at 4 ◦C) to HEPES supplemented with 1 mM EGTA or 1 mM EDTA provoked a
density shift to 1.195 g/mL, similar to the shift observed in the virus exposed to PBS. However, these
lighter particles were unstable and short exposure to 37 ◦C was sufficient to trigger a major density
shift, similar to that of virus in PBS and exposed to a freeze/thaw cycle. The rearrangement at 37 ◦C
was not observed in the absence of chelating agents (Figure 2C).
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Figure 2. Influence of divalent cation depletion on the density of B19V. Virus from infected plasma was
pelleted through 20% sucrose cushion, resuspended in different buffers and stored at 4 ◦C for one month.
Fractions from iodixanol density gradient ultracentrifugation were quantified by qPCR. (A) Effect of
prolonged (one month) incubation of B19V in MEM, HEPES and PBS at 4 ◦C. (B) Effect of a freeze/thaw
cycle after prolonged incubation of B19V in MEM, HEPES, PBS and PBS supplemented with 1 mM
CaCl2 or 1 mM MgCl2. (C) Effect of prolonged incubation of B19V in HEPES at 4 ◦C supplemented or
not with 1 mM EGTA or 1 mM EDTA. Before separation by iodixanol density centrifugation, the virus
suspensions were treated at 4 ◦C, 22 ◦C or 37 ◦C for 1 h. Green peak; density native virus. Red peak;
density free viral DNA. (D) Upper panel; summary of the major density peaks (g/mL) of B19V in the
different buffers and exposed to different conditions. Lower panel; graphic representation of the four
distinct density groups. Similar densities appear grouped by colours.
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In total, four density groups were identified (Figure 2D). Viruses in plasma or in buffers with
divalent cations were stable and had a similar density around 1.22 g/mL. Viruses exposed to buffers
with chelating activity peaked at a density of 1.19–1.20 g/mL. These particles shifted to 1.11–1.14 g/mL
when exposed to 37 ◦C or to a freeze/thaw cycle. Free viral DNA generated by heat treatment of virions
(60 ◦C or 80 ◦C for 5 min) peaked at 1.09 g/mL.
3.2. Depletion of Divalent Cations Facilitates B19V Uncoating without Capsid Disassembly
The capsid integrity of the different density populations was investigated by nuclease digestion
and by immunoprecipitation with the antibody 860-55D against a conformational epitope (Caps), which
recognizes only assembled capsids [44]. As shown in Figure 3A,B, capsids at densities ranging from
1.22–1.19 g/mL were mostly DNase I-resistant. Since the capsids were shortly exposed to 37 ◦C during
the DNase I treatment, virions with densities around 1.19 g/mL showed a variable degree of nuclease
sensitivity. However, capsids peaking at densities 1.11–1.14 g/mL were fully sensitive to nuclease
digestion, similarly to control virus heated at 80 ◦C. The viral capsids could be immunoprecipitated
under all tested conditions, except the control sample, which was exposed to 80 ◦C to provoke capsid
disassembly (Figure 3C,D). This result indicates that the structural rearrangements resulting in DNA
externalization do not compromise the integrity of the capsids, which remain assembled.
Negative stain transmission electron microscopy was used to visualize the effect on capsids
and the packaged DNA in the absence of divalent cations. In PBS supplemented with 1 mM MgCl2
(Figure 2B; density 1.23 g/mL), the capsids appear as stable, DNA-filled capsids. In contrast, in the
absence of MgCl2 and exposed to a freeze/thaw cycle (Figure 2B; major density peak at 1.11 and minor
density peak at 1.22), a mixture of empty and DNA-filled capsids was observed. Some capsids showed
an “eclipsing” effect, where the DNA appears condensed and rearranged, capturing an intermediate
step during genome release (Figure 3E). The infectivity of the virus preparations used for TEM was
evaluated by the quantification of the NS1 mRNA. While viruses supplemented with MgCl2 were
infectious, the infectivity dropped significantly in the absence of divalent cations (Figure 3F).
In summary, four density populations were characterized and are outlined in Figure 2D. Viruses in
plasma or in buffers with divalent cations were stable, nuclease resistant and had a similar density
around 1.22 g/mL. Viruses exposed for a prolonged time to buffers with chelating activity or to
chelating agents at low temperatures remained assembled but their density shifted to 1.19–1.20 g/mL.
These particles were unstable and exposure to 37 ◦C or to a freeze/thaw cycle was sufficient to trigger
the externalization of the viral DNA without capsid disassembly and to provoke a major density shift
to 1.11–1.14 g/mL. Finally, heating to 60 ◦C or 80 ◦C for 5 min caused the complete release of the
viral DNA, which peaked at 1.09 g/mL. These results together suggest that capsid-associated divalent
cations have a stabilizing role and their removal prepares the virus for uncoating at physiological
temperatures without capsid disassembly.
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Figure 3. DNA accessibility and capsid integrity of the different B19V density populations. (A,B)
Nuclease sensitivity of viruses in HEPES or in PBS displaying different densities. Virus samples from
representative density populations were treated with DNase I at 37 ◦C for 1 h (white columns). Virus
treated at 80 ◦C for 5 min was used as control. (C,D) Integrity of capsids in HEPES or in PBS displaying
different densities. Virus samples from representative density populations were immunoprecipitated
with the conformational antibody 860-55D against assembled capsids. Virus treated at 80 ◦C for 5 min
as used as control. (E) Transmission electron microscopy (TEM) images of B19V in PBS alone and PBS
supplemented with 1 mM MgCl2 and exposed to a freeze/thaw cycle. Arrows indicate capsids with
rearranged DNA. (F) Infectivity assay based on NS1 mRNA detection with the same B19V preparations
used for TEM. SE; short exposure. F/T; freeze and thaw. Values correspond to genome equivalents per
microliter (geq/µL).
3.3. A Proportion of Incoming Capsids Uncoat in the Cytoplasm without Capsid Disassembly
Cytoplasmic fractions were prepared from infected UT7/Epo cells. The lack of nuclear
contamination was confirmed by quantitative detection of β-actin gene sequences (Figure 4A).
The accessibility of the viral DNA from the incoming cytoplasmic virus was examined by nuclease
digestion and qPCR. While at 5 min pi the viral DNA remained protected, approximately half of
the incomi g genomes became se sitive to nuclease digestion after 3 h pi (Figure 4B). The VP1u
region is not accessible in native capsids but it becomes accessible upon interactions on the s rface of
susceptible cells [14,38]. As ex ected, cell-bound viruses were immunoprecipitated with the antibody
targeting a conformational e itope in VP2 (Caps) and by the antib dy targeting the PLA2 region
in VP1u (PLA2). Duri g cell entry, the PLA2 region remained accessible but the conformational
epitope in VP2 became undetectable in an increasing proportion of incoming particles (Figure 4C).
These results were further confirmed by immun recipitatio and Western blot analysis of capsid
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proteins. Incoming viruses were immunoprecipitated with Caps and PLA2 antibodies at 3 h pi.
The supernatant was used to immunoprecipitate remaining viruses with the heterologous antibody.
While the PLA2 antibody detected all intracellular capsids, the Caps antibody did not recognize a
significant proportion of incoming capsids (Figure 4D), suggesting that during entry some incoming
virions rearrange and adopt a configuration that remained recognized by the PLA2 antibody but not
by the VP2 conformational antibody.
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3.4. Uncoating Occurs after Endosomal Escape 
In order to examine whether the detected capsid rearrangement and DNA externalization occur 
before or after endosomal escape, cells were treated with bafilomycin A1 (BafA1), which was 
previously shown to block endosomal escape of B19V [9]. The cells were fixed 30 min and 5 h pi and 
Figure 4. Capsid structural rearrangements and viral DNA externalization in the cytoplasm. (A) The
purity of the cytoplasmic fraction and the absence of nuclear contamination were examined by
quantitative detection of β-actin gene sequences. Values represent DNA copies per microliter. (B)
Nuclease sensitivity of virions at 5 min and 3 h pi Virus treated at 60 ◦C for 5 min was used as control.
(C) Accessibility of VP1u (PLA2 antibody) and VP2 conformational (Caps antibody) epitopes from
membrane-bound or intracellular B19V. Virions were immunoprecipitated and quantified by qPCR.
As control, an unrelated IgG was used. (D) Western blot of B19V immunoprecipitated at 3 h pi. The
supernatants were used for a second immunoprecipitation with the indicated antibodies. (E) Nuclease
sensitivity of B19V immunoprecipitated with the conformational antibody (Caps) or with the VP1u
antibody (PLA2) at 1 h pi. All immunoprecipitation values represent geq/µL.
We next verified whether the observed capsid structural rearrangement rendered the viral DNA
accessible. To explore this possibility, virions from cytoplasmic fractions were immunoprecipitated
with the Caps or with the PLA2 antibody 3 h pi and the accessibility of the viral DNA from the
immunoprecipitated capsids was examined by nuclease digestion and qPCR. The incoming capsids that
re ained detectable by the conformational antibody were resistant to nuclease digestion. In contrast,
approximately half of the virions that were immunoprecipitated with the PLA2 antibody were sensitive
to nuclease digestion (Figure 4E). This result suggests that a significant proportion of incoming capsids
uncoat in the cytoplasm through a limited capsid rearrangement.
3.4. Uncoating Occurs after Endosomal Escape
In order to examine whether the detected capsid rearrangement and DNA externalization occur
before or after endosomal escap , cells were treated with bafilomycin A1 (BafA1), which was previously
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shown to block endosomal escape of B19V [9]. The cells were fixed 30 min and 5 h pi and incoming
viruses were detected with the conformational antibody (Caps). After 30 min, a similar signal with
a characteristic endocytic distribution was observed in untreated or BafA1-treated cells. However,
5 h pi the number of capsids detectable with the conformational antibody decreased significantly in
the untreated cells, but remained stable in the BafA1-treated cells and displayed the same endocytic
distribution, indicating that endosomal escape and the capsid rearrangement were inhibited (Figure 5A).
The capsid rearrangement and the accessibility of the DNA were also examined by immunoprecipitation
and nuclease digestion. As shown in Figure 5B, while in untreated cells a proportion of incoming
capsids rearranged and became nuclease sensitive, in the presence of BafA1 the capsids remained
mostly unchanged.
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Figure 5. Conformational epitope rearrangement, DNA externalization and phosphorylation occur
after endosomal escape. (A) Effect of BafA1 and CQ on endosomal escape and conformational epitope
integrity. Immunofluorescence images of infected cells treated or not with BafA1 (20 nM) and CQ
(25 µM). The integrity of the conformational epitope and the characteristic endocytic clustering of
the virus was examined by staining with the conformational antibody (Caps) at 30 min and 3 h pi.
Arrows indicate the presence of enlarged endosomes in cells treated with CQ. (B) Effect of BafA1 and
CQ on the conformational rearrangement and nuclease sensitivity of the incoming virions. The virions
were immunoprecipitated from infected cells at 3 h pi and quantified by qPCR, values correspond to
geq/µL. (C) Kinetics of B19V phosphorylation. At increasing times pi, virions were immunoprecipitated
from cytoplasmic fractions with PLA2 (total virions) or with an antibody against phosphotyrosine
and quantified by qPCR. (D) Phosphatase treatment abrogated the reactivity with the phosphospecific
antibody. Before immunoprecipitation, the intracellular capsids were treated or not with lambda
phosphatase (500 U) for 1 h at 30 ◦C. (E) Effect of BafA1 (20 nM) or CQ (25 µM) on B19V phosphorylation.
Virions from cytoplasmic fractions were immunoprecipitated with the phosphotyrosine antibody at 3h
pi and quantified by qPCR. As control, an unrelated IgG was used.
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These results are in line with our previous studies where we have shown that BafA1 inhibits B19V
infection by blocking endosomal escape. In the same studies, we observed that chloroquine (CQ),
which also raises endosomal pH, did not hinder endosomal escape [9], an effect that was attributed
to the vacuolization and damage of endocytic vesicles [17]. Accordingly, CQ was used to verify
whether the inhibitory effect of BafA1 on the rearrangement and DNA accessibility is due to the raise
in the endosomal pH or to the block of endosomal escape. As shown in Figure 5A,B, CQ induced
the enlargement of endocytic vesicles and did not prevent the capsid rearrangement and viral DNA
externalization, suggesting that these changes ensue only after endosomal escape and are not mediated
by the low endocytic pH.
3.5. Incoming Capsids Become Reactive to Phosphospecific Antibodies Following Endosomal Escape
Cellular kinases have been shown to phosphorylate incoming parvovirus capsids following
endosomal escape [45]. We investigated whether B19V is also phosphorylated after endosomal
escape. To this end, cell-bound and internalized capsids were incubated with a phosphospecific
antibody targeting tyrosine phosphorylation. Quantification of the immunoprecipitated capsids by
qPCR revealed that by 1 h pi, approximately half of the internalized capsids became phosphorylated
(Figure 5C). Capsid phosphorylation initiated as early as 10 min pi and was maximal between 30 min
and 1 h pi. Incoming B19V were not reactive to phosphospecific antibodies following incubation with
lambda phosphatase (Figure 5D). As expected, inhibition of endosomal escape by BafA1 abrogated
capsid phosphorylation. In contrast, phosphorylation was not prevented in the presence of CQ
(Figure 5E), confirming our previous observations indicating that CQ does not hinder endosomal
escape [9]. These results further demonstrate that the observed capsid rearrangement and DNA
accessibility are not triggered by the endosomal low pH but following the delivery of incoming particles
into the cytosol.
3.6. Capsids Phosphorylated and with Accessible Genomes Accumulated Progressively in the Nuclear Fraction
All the described capsid structural changes, i.e., conformational epitope rearrangement,
phosphorylation and DNA externalization, were observed in virions isolated from the cytoplasmic
fraction devoid of nucleus. We next analysed the presence of viral DNA and capsids in the nuclear
fraction at increasing times pi. The integrity of the isolated nuclei was assessed by light microscopy after
trypan blue staining and the purity of the nuclear fraction was verified by the absence of cytoplasmic
contamination using antibodies against GAPDH (cytosolic marker), lamin A/C (nuclear inner membrane
marker) and SERCA2 ATPase (endoplasmic reticulum marker) (Figure 6A). Nuclei isolated after 5 min
or from cells treated with BafA1 to prevent endosomal escape served as negative controls. Viral DNA
was quantified from the purified nuclei by qPCR and the results were normalized by the quantification
of the β-actin gene. An increasing amount of viral DNA accumulated in the nuclear fraction reaching a
plateau by 2–3 h pi. In contrast, nuclear viral DNA did not increase significantly above the background
level in cells treated with BafA1 (Figure 6B).
The accessibility of the viral DNA accumulating in the nuclear fraction was examined by nuclease
digestion. Purified nuclei were prepared at 5 min (negative control) and 3 h pi. While the DNA
detected 5 min pi, representing the background, was resistant to nucleases, the viral DNA accumulated
in the nuclear fraction at 3 h pi was mostly nuclease sensitive. Incubation of the nuclear fraction at
60 ◦C for 10 min was used to control the activity of DNase I (Figure 6C).
We next analysed whether the nuclear viral DNA signal originated from free or capsid-associated
DNA. To this end, nuclear fractions were prepared at 5 min (negative control) and 3 h pi and used for
immunoprecipitation with the Caps, PLA2 and phosphotyrosine antibody. The immunoprecipitated
viruses were quantified by qPCR, as specified above. Additionally, the accessibility of the viral DNA
was examined by treatments with DNase I. The results showed that only the capsids that underwent the
structural modifications in the cytoplasm, i.e., conformational epitope rearrangement, phosphorylation
and DNA externalization, were able to reach the nucleus (Figure 6D).
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Figure 6. Characterization of incoming B19V associated to the nuclear fraction. (A) Isolation of
intact nuclei without cytoplasmic contamination. The purity of the nuclear fraction and the absence
of cytoplasmic contamination were examined by the detection of lamin A/C (nuclear marker) and
SERCA2 ATPase (ER marker) and GAPDH (cytoplasmic marker) by Western blot. Nuc1 and Nuc2; two
independent nuclear preparations. (B) Accumulation of B19V in the nuclear fraction at increasing times
pi. Nuclei isolated after 5 min or from cells treated with BafA1 served as negative controls. The results
were normalized by the quantification of the β-actin-like gene 2 (ACTBL2). (C) Nuclease sensitivity of
virions associated to the nuclear fraction. Nuclei isolated after 5 min served as background control.
Nuclear fractions prepared 3 h pi were treated at 60 ◦C for 5 min to control the activity of DNase I.
qPCR values represent geq/µL. (D) Immunoprecipitation of virions associated to the nuclear fraction.
Nuclei isolated after 5 min served as background control. pTyr; phosphotyrosine antibody. qPCR
values represent geq/µL.
3.7. Nuclear Targeting of B19V Is Mediated by the Microtubule-Dependent, Minus-End-Directed
Motor Dynein
Cytoplasmic dynein mediates ATP-dependent retrograde movement of cargoes, including
endocytic vesicles, along microtubules toward the centrosome near the nucleus [46]. Accordingly,
endocytosed B19V can indirectly benefit from this transport. However, it remains unclear whether
parvovirus particles can directly engage motor proteins when they are released in the cytosol for
their own transport to the nuclear vicinity. In order to address this question, ciliobrevin D (CbD),
which is a specific inhibitor of AAA+ ATPase motor cytoplasmic dynein, was used. CbD inhibits
dynein function without altering microtubule structure and dynamics [47,48]. In order to not disturb
dynein-mediated endocytic transport of B19V and release from endosomes, cells were treated with CbD
15 min after internalization, at a time when most of the intracellular viruses are in late endosomes [9].
Under these experimental conditions, the loss of the conformational epitope (Caps/PLA2 ratio), capsid
phosphorylation and DNA externalization were not disturbed by CbD (Figure 7A,B). In contrast, the
accumulation of viruses in the nuclear fraction was prevented. Release of the reversible CbD block
resulted in an increased nuclear accumulation of viruses (Figure 7C). As expected, disruption of dynein
function by CbD impaired B19V infection, but only when present early during virus entry and not at
later times pi (Figure 7D).
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inhibitor ciliobrevin D (CbD; 100 µM) on conformational epitope integrity (Caps/PLA2 ratio). (B) ffect
f CbD o phosphorylation and DNA externalization. (C) Effect of CbD on th nuclear accumulation
of B19V DNA. After 5 min (background control) and 3 h pi, cells were washed and the amount of
viral DNA was qua tified by qPCR. dditionally, cells were incubated for two additional hours in
the presence or absence of CbD. All values of qPCR correspond to geq/µL. (D) Effect of CbD on B19V
infection. Cells were infected in the presence of CbD for the indicated times and the amount of NS1
mRNA was quantified by RT-qPCR at 22 h pi. Values represent NS1 mRNA copies/µL.
3.8. Capsids Immunoprecipitated from Cytoplasmic and from Nuclear Fractions Support
Complementary-Strand DNA Synthesis
The strategy fo omplementar -str nd sy thesis is outlined in Fig re 8A. Cytoplasmic and
nuclear capsids w re immunoprecipitated with the antibody against the PLA2 region, which remains
accessible during cell entry. The presence of externalized DNA in the immunoprecipitated capsids and
its suitability as template for complementary-strand synthesis were examined by hybridization with
primers targeting the 3’ or the 5’ region of the viral genome (outlined in Figure 8B). The oligonucleotides
consisted of a 3’ virus-specific sequence (specific for a sequence stretch at the 3’ or 5’ regions) and
a 5’ virus–unrelated sequence. Following the hybridization reaction at 37 ◦C, the extension was
performed at 37 ◦C for 15 min. Negative controls consisted of viruses immunoprecipitated at 5 min
pi or viruses immunoprecipitated at 3 h pi without the polymerase extension step. The reaction was
stopped, and the primer-extended DNA was amplified by real-time PCR using a forward primer
specific for the 5’ virus-unrelated sequences of the oligonucleotide and a virus-specific reverse primer.
Only capsids immunoprecipitated from cytoplasmic fractions or from nuclear fractions at 3 h pi
originated the expected PCR product, indicating the presence of accessible DNA templates from
the immunoprecipitated capsids. Similar results were obtained by using primers targeting the 3’
or the 5’ region of the viral genome (Figure 8C). DNA accessibility was not detected from capsids
immunoprecipitated after 5 min of internalization or in samples without polymerase extension.
These results indicate that the viral DNA becomes accessible already in the cytoplasm prior to
nuclear entry and supports complementary-strand synthesis while remaining associated to the
assembled particle.
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Figure 8. Complementary-strand DNA synthesis from cytoplasmic or nuclear capsids. (A) Depiction
of the strategy for complementary-strand synthesis: (a) Immunoprecipitation of B19V capsids with
the PLA2 antibody; (b) 5’ virus-unrelated sequence; (c) extension reaction by T7 polymerase at 37 ◦C;
and (d) amplification of the primer-extended DNA by PCR. (B) Positions in the B19V genome of the 3’
(yellow) and 5’ (red) regions targeted by the hybridization and extension assay. (C) Viral particles were
immunoprecipitated from cytoplasmic or from nuclear fractions with the antibody against the PLA2
region (PLA2) and used for complementary-strand DNA synthesis. The primer-extended DNA was
amplified by PCR and amplicons of the expected size were visualized by agarose gel electrophoresis.
As controls, viruses were immunoprecipitated 5 min pi or incubated with the T7 polymerase for only a
few seconds.
4. Discussion
Parvovirus infection critically depends on the processing of the incoming particles by cellular
factors to promote their transport into the nucleus and the delivery of the viral genome for replication.
How and where human parvovi us B19 (B19V) rele ses viral DNA and which capsid rea rangeme t
are required for the process is currently unknown. In this study, we combined in vitro and in vivo
experiments to dd ss the mechanism of uncoating of B19V.
A common parvovirus structural feature the combination of antiparallel β-hairpins at the
five-fold vertex enclosing a cylindric l structure that nnects with the interior of the ca sid [35,49–52].
Structu al and in vitro studies suggest hat ese channels serve as portals or the externalization
of N-te minal capsid protein equ nces required during the process of vi us entry and for the
packagi g and release of th viral genome [23,31–34,52–54]. Mutations that perturb the stru ture of
the channel result in defective genome encapsidation, uncoa ing and VP1u x ernalization [30,31,39].
Those mutational studies have also confirmed th t MVM cylinders can medi e progressive 3′-to-5′
genome re ease, suggesting that this is the s rategy of u coating, and that unknown cellular trigger(s)
may initiate the DNA rearrangement during virus entry [39]. In B19V, the channel does not mediate
the externalization of N-VP2 sequences, which are already exposed [55], an N-VP1 migh also
occupy a surface position not acces ible to antibodies until th interaction of the vir on with cell lar
receptors [14,15]. Accordingly, the ma n functio of the channel in B19V would be th packaging and
release of the viral genome. However, different to oth r parvoviruses, the channel in B19 VP2 capsids
is constricted at its outside end, although three consecuti e glycine residues at this site may rovide
enough flexibility to open the channel upon specific cellular cues [35].
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Iodixanol density gradient ultracentrifugation followed by qPCR detection of the viral DNA proved
to be a useful approach to detect and quantify structural rearrangements in the viral capsid. The method
allowed to explore conditions triggering the uncoating reaction at physiological temperatures and to
identify and characterize uncoating intermediates. Native capsids in human plasma or in MEM were
stable and remained intact after exposure to 37 ◦C or to a freeze/thaw cycle. However, in the absence of
divalent cations or in the presence of chelating activity at 4 ◦C, the viral capsids rearranged resulting
in particles with a lower density and mostly resistant to nuclease digestion. These capsids however
were rather unstable and incubation at 37 ◦C or a freeze/thaw cycle was sufficient to trigger viral DNA
externalization without capsid disassembly. These rearrangements were prevented in the presence of 1
mM MgCl2 or 1 mM CaCl2, strongly suggesting that divalent cations have a stabilizing effect on the viral
particle and their removal facilitates the uncoating reaction at physiological temperatures. The TEM
images confirmed the presence of assembled particles with variable degree of DNA externalization
(Figure 3E), explaining their broader iodixanol density profile (Figure 2). Similar results were obtained
with minute virus of mice (MVM). Depletion of capsid-associated divalent cations in MVM rendered
the virions unstable and exposure to 37 ◦C triggered the externalization of the genome, in a 3′-to-5′
direction, leaving the 5′ end of the DNA associated with the capsid. The process was not observed in
the presence of divalent cations or in capsids with shorter genomes [42].
During packaging, the viral DNA is loaded at a high density into the small inner cavity of the
pre-formed capsids in a 3’ to 5’ direction through the fivefold cylinder [31,33,56,57]. It is conceivable,
that in order to condensate and stabilize the DNA-filled capsid, divalent cations may be incorporated
into the B19 progeny particle during packaging to neutralize the negative charges of closely packed DNA
phosphate backbones and eventually also negative charges in the particle lattice interior. The highly
condensed DNA generates a considerable internal pressure and loss of capsid-associated divalent
cations during entry may increase the internal tension and destabilize the whole structure, provoking
the externalization of the viral genome through the fivefold channel without the need to disassemble
the capsid. A direct correlation between the amount of encapsidated DNA and the sensitivity to
chelating agents was demonstrated for a variety of of viruses [58,59], including different rAAV vectors
and MVM [37,40,42]. Divalent cations may also bind the capsid to cement the structure, as it has
been demonstrated for other viruses, and their removal was shown to destabilize the capsid and
promote uncoating [60–64]. Prediction of metal ions binding sites by IonCom, which combines the ab
initio model with multiple threading alignments [65], revealed a Mg2+ and Ca2+ binding site in close
proximity on the surface of B19V capsid. While the Mg2+ binding domain was slightly buried, the
Ca2+ binding site appeared on the surface surrounding the dimple-like depression at the icosahedral
two-fold axis of symmetry (data not shown).
The similar response of MVM and B19V to divalent cation depletion may reflect a common
uncoating strategy of parvoviruses based on a mechanism of DNA externalization without capsid
disassembly. This strategy would allow the exceptionally stable parvoviral particles to deliver the
genome inside the host cells, and since the particle and the viral DNA remain associated, the capsid
can transport the externalized genome to the precise nuclear location to initiate replication and
transcription. The destabilization and uncoating of B19 virions under divalent cation depletion in vitro
suggests a mechanism for viral genome release in low-divalent-cation environments, such as those
typically encountered within the cytosol of the cell, where the activities of ATP-driven Ca2+ pumps
and Na+/Ca2+ exchangers maintain the concentration of Ca2+ ions at a very low (10–100 nM) level [66].
Therefore, following endosomal escape, the virion is abruptly exposed to a divalent cation-depleted
environment in the cytosol, which may destabilize the incoming particle. However, although the
in vitro studies reveal important information on conditions allowing the uncoating reaction and allow
the characterization of uncoating intermediates, these studies do not necessarily reflect the uncoating
process in vivo, which may differ in its mechanism and be triggered by intracellular factor(s) other
than divalent cation depletion. With the aim to get insights into the intracellular capsid processing
required for B19V uncoating in vivo, we followed capsid modifications and changes in epitope and
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DNA accessibility during B19V entry. These rearrangements were examined in UT7/Epo cells at various
times pi from cytoplasmic and nuclear fractions and under different conditions restraining endosome
and dynein functions.
The first detectable capsid rearrangement during B19V entry was the change in VP1u configuration
occurring at the plasma membrane before virus internalization. For most parvoviruses, VP1u
externalization occurs inside the endosomes triggered by the acidic environment [11,23,67–69].
However, we have previously shown that B19V operates differently. Upon interactions on the surface
of susceptible cells, originally inaccessible VP1u sequences become exposed [13] and interact with as
yet unknown highly restricted receptor required for virus uptake [14,15]. As expected, cell-bound
virions were immunoprecipitated with the antibody against VP1u (PLA2) and the conformational
antibody detecting exclusively intact capsids (Caps) (Figure 4C).
The second capsid rearrangement detected was more complex and occurred after endosomal
escape in the cytoplasm. While the capsids remained detectable by the VP1u antibody, approximately
half of them became undetectable by the conformational antibody against capsids (Figure 4C,D).
The capsids that rearranged became sensitive to nuclease digestion in contrast to those that had not
rearranged (Figure 4E). The conformational epitope expands three neighboring VP2 molecules related
by a five-fold axis and by a three-fold axis [43], and its loss can be explained by a rearrangement
occurring at this site. Alternatively, epitope masking by phosphorylation might prohibit antibody
binding. In line with this assumption, approximately the same number of incoming capsids that
rearranged became phosphorylated (Figure 5C), a process that can only occur after endosomal escape.
As expected, endosomal alkalization by bafilomycin A1 (BafA1) abrogated endosomal escape and all
the capsid rearrangements, including the phosphorylation (Figure 5A,B,E). Similar to BafA1, CQ also
raises the endosomal pH but, in contrast to BafA1, CQ promotes B19V endosomal escape by endosome
swelling and rupture (Figure 5A) [9]. Accordingly, alkalization of endosomes by CQ had no effect on
B19V capsid rearrangement and phosphorylation (Figure 5B,E).
Incoming B19V accumulated progressively in the nuclear fraction reaching a plateau by 2 h pi.
As expected, blocking endosomal escape by BafA1 prevented the nuclear accumulation of the capsids
(Figure 6B). While the capsids present in the cytoplasmic fraction represented a mixture of intact
and rearranged particles, the capsids associated to the nuclear fraction were mostly those that had
rearranged, i.e., phosphorylated, undetectable by the conformational antibody and nuclease sensitive,
suggesting the existence of a selective transport towards the nucleus for the capsids with accessible
genomes. The accumulation of B19V capsids in the nuclear fraction was reversibly abrogated by
ciliobrevin D (CbD), which is a specific inhibitor of the ATPase activity of cytoplasmic dynein [47].
CbD had no effect on the capsid rearrangements in the cytoplasm, including phosphorylation and
genome externalization. The interference of dynein function had a significant inhibitory effect on
the infection, but only when the reversible drug was present during the first hours of the infection
(Figure 7), indicating that the accumulation of the incoming capsids with accessible genomes in the
nuclear fraction is required for the infection. At present, it is uncertain how many of these particles are
inside the nucleus and how many remain at the cytosolic side.
The primer hybridization and extension assay confirmed that incoming B19V particles expose the
genome already in the cytoplasm prior to nuclear entry, and that the accessible DNA was an optimal
template for complementary-strand synthesis (Figure 8). This observation suggests that initiation of
DNA synthesis can proceed while the exposed genome remains associated to its capsid.
This study provides a better understanding of the conditions triggering B19V uncoating at
physiological temperatures and allowed the identification of capsid structural transitions that precede
genome release. Whether incoming viruses are destabilized by the low-cation environment of the
cytosol, as suggested by the in vitro data or by another cellular cue, will have to be confirmed.
However, our in vivo data reveal that during the process of entry, B19V employs a mechanism of
DNA externalization following a limited capsid rearrangement in the cytoplasm to make the genome
sufficiently accessible to the replication machinery of the cell.
Viruses 2019, 11, 430 18 of 21
Author Contributions: C.R. supervised project; C.R., O.C. and N.R. conceived and designed the experiments;
O.C., N.R. and A.M. performed the experiments and analysed the data; S.S. and S.H. performed TEM; C.R. wrote
the paper and O.C. and R.L. thoroughly revised it.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Young, N.S.; Brown, K.E. Parvovirus B19. N. Engl. J. Med. 2004, 350, 586–597. [CrossRef] [PubMed]
2. Servey, J.T.; Reamy, B.V.; Hodge, J. Clinical presentations of parvovirus B19 infection. Am. Fam. Physician
2007, 75, 373–376. [PubMed]
3. Cotmore, S.F.; Mckie, V.C.; Anderson, L.J.; Astell, C.R.; Tattersall1, P.; Tattersall, P. Identification of the Major
Structural and Nonstructural Proteins Encoded by Human Parvovirus B19 and Mapping of Their Genes by
Procaryotic Expression of Isolated Genomic Fragments. J. Virol. 1986, 60, 548–557. [PubMed]
4. Kilcher, S.; Mercer, J. DNA virus uncoating. Virology 2015, 479–480, 578–590. [CrossRef] [PubMed]
5. Suomalainen, M.; Greber, U.F. Uncoating of non-enveloped viruses. Curr. Opin. Virol. 2013, 3, 27–33.
[CrossRef] [PubMed]
6. Ravindran, M.S.; Tsai, B. Viruses Utilize Cellular Cues in Distinct Combination to Undergo Systematic
Priming and Uncoating. PLoS Pathog. 2016, 12, e1005467. [CrossRef]
7. Yamauchi, Y.; Greber, U.F. Principles of Virus Uncoating: Cues and the Snooker Ball. Traffic 2016, 17, 569–592.
[CrossRef]
8. Ros, C.; Bayat, N.; Wolfisberg, R.; Almendral, J.M. Protoparvovirus Cell Entry. Viruses 2017, 9, 313. [CrossRef]
9. Quattrocchi, S.; Ruprecht, N.; Bönsch, C.; Bieli, S.; Zürcher, C.; Boller, K.; Kempf, C.; Ros, C. Characterization
of the early steps of human parvovirus B19 infection. J. Virol. 2012, 86, 9274–9284. [CrossRef]
10. Cotmore, S.F.; Tattersall, P. Parvoviral Host Range and Cell Entry Mechanisms. Adv. Virus Res. 2007, 70,
183–232.
11. Harbison, C.E.; Chiorini, J.A.; Parrish, C.R. The parvovirus capsid odyssey: From the cell surface to the
nucleus. Trends Microbiol. 2008, 16, 208–214. [CrossRef]
12. Parrish, C.R. Structures and Functions of Parvovirus Capsids and the Process of Cell Infection; Springer:
Berlin/Heidelberg, Germany, 2010; pp. 149–176.
13. Bönsch, C.; Kempf, C.; Ros, C. Interaction of parvovirus B19 with human erythrocytes alters virus structure
and cell membrane integrity. J. Virol. 2008, 82, 11784–11791. [CrossRef]
14. Bönsch, C.; Zuercher, C.; Lieby, P.; Kempf, C.; Ros, C. The globoside receptor triggers structural changes in
the B19 virus capsid that facilitate virus internalization. J. Virol. 2010, 84, 11737–11746. [CrossRef]
15. Leisi, R.; Ruprecht, N.; Kempf, C.; Ros, C. Parvovirus B19 uptake is a highly selective process controlled by
VP1u, a novel determinant of viral tropism. J. Virol. 2013, 87, 13161–13167. [CrossRef]
16. Leisi, R.; Von Nordheim, M.; Ros, C.; Kempf, C. The VP1u Receptor Restricts Parvovirus B19 Uptake to
Permissive Erythroid Cells. Viruses 2016, 8, 265. [CrossRef]
17. Zhang, W.; Tung, C.-H. Lysosome Enlargement Enhanced Photochemotherapy Using a Multifunctional
Nanogel. ACS Appl. Mater. Interfaces 2018, 10, 4343–4348. [CrossRef]
18. Suikkanen, S.; Aaltonen, T.; Nevalainen, M.; Välilehto, O.; Lindholm, L.; Vuento, M.; Vihinen-Ranta, M.
Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J. Virol.
2003, 77, 10270–10279. [CrossRef]
19. Kelkar, S.; De, B.P.; Gao, G.; Wilson, J.M.; Crystal, R.G.; Leopold, P.L. A common mechanism for cytoplasmic
dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes. J.
Virol. 2006, 80, 7781–7785. [CrossRef]
20. Hirosue, S.; Senn, K.; Clément, N.; Nonnenmacher, M.; Gigout, L.; Linden, R.M.; Weber, T. Effect of
inhibition of dynein function and microtubule-altering drugs on AAV2 transduction. Virology 2007, 367,
10–18. [CrossRef]
21. Lyi, S.M.; Tan, M.J.A.; Parrish, C.R. Parvovirus particles and movement in the cellular cytoplasm and effects
of the cytoskeleton. Virology 2014, 456–457, 342–352. [CrossRef]
22. Vihinen-Ranta, M.; Kakkola, L.; Kalela, A.; Vilja, P.; Vuento, M. Characterization of a Nuclear Localization
Signal of Canine Parvovirus Capsid Proteins. Eur. J. Biochem. 1997, 250, 389–394. [CrossRef]
Viruses 2019, 11, 430 19 of 21
23. Sonntag, F.; Bleker, S.; Leuchs, B.; Fischer, R.; Kleinschmidt, J.A. Adeno-Associated Virus Type 2 Capsids
with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and
Are Maintained until Uncoating Occurs in the Nucleus. J. Virol. 2006, 80, 11040. [CrossRef]
24. Johnson, J.S.; Li, C.; DiPrimio, N.; Weinberg, M.S.; McCown, T.J.; Samulski, R.J. Mutagenesis of
adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and
cell-specific transduction. J. Virol. 2010, 84, 8888–8902. [CrossRef]
25. Popa-Wagner, R.; Porwal, M.; Kann, M.; Reuss, M.; Weimer, M.; Florin, L.; Kleinschmidt, J.A. Impact of
VP1-Specific Protein Sequence Motifs on Adeno-Associated Virus Type 2 Intracellular Trafficking and Nuclear
Entry. J. Virol. 2012, 86, 9163. [CrossRef]
26. Nicolson, S.C.; Samulski, R.J. Recombinant adeno-associated virus utilizes host cell nuclear import machinery
to enter the nucleus. J. Virol. 2014, 88, 4132–4144. [CrossRef]
27. Cohen, S.; Marr, A.K.; Garcin, P.; Panté, N. Nuclear envelope disruption involving host caspases plays a role
in the parvovirus replication cycle. J. Virol. 2011, 85, 4863–4874. [CrossRef]
28. Fay, N.; Panté, N. Old foes, new understandings: Nuclear entry of small non-enveloped DNA viruses. Curr.
Opin. Virol. 2015, 12, 59–65. [CrossRef]
29. Lux, K.; Goerlitz, N.; Schlemminger, S.; Perabo, L.; Goldnau, D.; Endell, J.; Leike, K.; Kofler, D.M.; Finke, S.;
Hallek, M.; et al. Green fluorescent protein-tagged adeno-associated virus particles allow the study of
cytosolic and nuclear trafficking. J. Virol. 2005, 79, 11776–11787. [CrossRef]
30. Farr, G.A.; Tattersall, P. A conserved leucine that constricts the pore through the capsid fivefold cylinder
plays a central role in parvoviral infection. Virology 2004, 323, 243–256. [CrossRef]
31. Bleker, S.; Sonntag, F.; Kleinschmidt, J.A. Mutational analysis of narrow pores at the fivefold symmetry
axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of
phospholipase A2 activity. J. Virol. 2005, 79, 2528–2540. [CrossRef]
32. Farr, G.A.; Cotmore, S.F.; Tattersall, P. VP2 cleavage and the leucine ring at the base of the fivefold cylinder
control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice.
J. Virol. 2006, 80, 161–171. [CrossRef]
33. Plevka, P.; Hafenstein, S.; Li, L.; D’Abrgamo, A.; Cotmore, S.F.; Rossmann, M.G.; Tattersall, P.; Tattersall, P.
Structure of a packaging-defective mutant of minute virus of mice indicates that the genome is packaged via
a pore at a 5-fold axis. J. Virol. 2011, 85, 4822–4827. [CrossRef]
34. Cotmore, S.F.; Tattersall, P. Parvoviruses: Small Does Not Mean Simple. Annu. Rev. Virol. 2014, 1, 517–537.
[CrossRef]
35. Kaufmann, B.; Simpson, A.A.; Rossmann, M.G. The structure of human parvovirus B19. Proc. Natl. Acad. Sci.
USA 2004, 101, 11628–11633. [CrossRef]
36. Cotmore, S.F.; D’Abramo, A.M.; Ticknor, C.M.; Tattersall, P. Controlled Conformational Transitions in the
MVM Virion Expose the VP1 N-Terminus and Viral Genome without Particle Disassembly. Virology 1999,
254, 169–181. [CrossRef]
37. Turnbull, A.E.; Skulimowski, A.; Smythe, J.A.; Alexander, I.E. Adeno-Associated Virus Vectors Show Variable
Dependence on Divalent Cations for Thermostability: Implications for Purification and Handling. Hum.
Gene Ther. 2000, 11, 629–635. [CrossRef]
38. Ros, C.; Baltzer, C.; Mani, B.; Kempf, C. Parvovirus uncoating in vitro reveals a mechanism of DNA release
without capsid disassembly and striking differences in encapsidated DNA stability. Virology 2006, 345,
137–147. [CrossRef]
39. Cotmore, S.F.; Tattersall, P. Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice
induce 3’-to-5’ genome uncoating and critically impair entry functions. J. Virol. 2012, 86, 69–80. [CrossRef]
40. Horowitz, E.D.; Rahman, K.S.; Bower, B.D.; Dismuke, D.J.; Falvo, M.R.; Griffith, J.D.; Harvey, S.C.; Asokan, A.
Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome
release. J. Virol. 2013, 87, 2994–3002. [CrossRef]
41. Bernaud, J.; Rossi, A.; Fis, A.; Gardette, L.; Aillot, L.; Büning, H.; Castelnovo, M.; Salvetti, A.;
Faivre-Moskalenko, C. Characterization of AAV vector particle stability at the single-capsid level. J.
Biol. Phys. 2018, 44, 181–194. [CrossRef]
42. Cotmore, S.F.; Hafenstein, S.; Tattersall, P. Depletion of virion-associated divalent cations induces parvovirus
minute virus of mice to eject its genome in a 3’-to-5’ direction from an otherwise intact viral particle. J. Virol.
2010, 84, 1945–1956. [CrossRef]
Viruses 2019, 11, 430 20 of 21
43. Sun, Y.; Klose, T.; Liu, Y.; Modrow, S.; Rossmann, M.G. Structure of parvovirus B19 decorated by Fabs from a
human antibody. J. Virol. 2019. [CrossRef]
44. Gigler, A.; Dorsch, S.; Hemauer, A.; Williams, C.; Kim, S.; Young, N.S.; Zolla-Pazner, S.; Wolf, H.; Gorny, M.K.;
Modrow, S. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J.
Virol. 1999, 73, 1974–1979.
45. Zhong, L.; Li, B.; Jayandharan, G.; Mah, C.S.; Govindasamy, L.; Agbandje-McKenna, M.; Herzog, R.W.;
Weigel-Van Aken, K.A.; Hobbs, J.A.; Zolotukhin, S.; et al. Tyrosine-phosphorylation of AAV2 vectors and
its consequences on viral intracellular trafficking and transgene expression. Virology 2008, 381, 194–202.
[CrossRef]
46. Roberts, A.J.; Kon, T.; Knight, P.J.; Sutoh, K.; Burgess, S.A. Functions and mechanics of dynein motor proteins.
Nat. Rev. Mol. Cell Biol. 2013, 14, 713–726. [CrossRef]
47. Firestone, A.J.; Weinger, J.S.; Maldonado, M.; Barlan, K.; Langston, L.D.; O’Donnell, M.; Gelfand, V.I.;
Kapoor, T.M.; Chen, J.K. Small-molecule inhibitors of the AAA+ ATPase motor cytoplasmic dynein. Nature
2012, 484, 125–129. [CrossRef]
48. Sainath, R.; Gallo, G. The Dynein Inhibitor Ciliobrevin D Inhibits the Bi-directional Transport of Organelles
along Sensory Axons and Impairs NGF- Mediated Regulation of Growth Cones and Axon Branches. Dev.
Neurobiol. 2015, 75, 757–777. [CrossRef]
49. Tsao, J.; Chapman, M.S.; Agbandje, M.; Keller, W.; Smith, K.; Wu, H.; Luo, M.; Smith, T.J.; Rossmann, M.G.;
Compans, R.W.; et al. The three-dimensional structure of canine parvovirus and its functional implications.
Science 1991, 251, 1456–1464. [CrossRef]
50. Chapman, M.S.; Rossmann, M.G. Structure, Sequence, and Function Correlations among Parvoviruses.
Virology 1993, 194, 491–508. [CrossRef]
51. Llamas-Saiz, A.L.; Agbandje-McKenna, M.; Wikoff, W.R.; Bratton, J.; Tattersall, P.; Rossmann, M.G. IUCr
Structure Determination of Minute Virus of Mice. Acta Crystallogr. Sect. D Biol. Crystallogr. 1997, 53, 93–102.
[CrossRef]
52. Agbandje-McKenna, M.; Llamas-Saiz, A.L.; Wang, F.; Tattersall, P.; Rossmann, M.G. Functional implications
of the structure of the murine parvovirus, minute virus of mice. Structure 1998, 6, 1369–1381. [CrossRef]
53. Kronenberg, S.; Böttcher, B.; von der Lieth, C.W.; Bleker, S.; Kleinschmidt, J.A. A conformational change in
the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J. Virol. 2005, 79,
5296–5303. [CrossRef]
54. Castellanos, M.; Pérez, R.; Rodríguez-Huete, A.; Grueso, E.; Almendral, J.M.; Mateu, M.G. A slender tract of
glycine residues is required for translocation of the VP2 protein N-terminal domain through the parvovirus
MVM capsid channel to initiate infection. Biochem. J. 2013, 455, 87–94. [CrossRef]
55. Kaufmann, B.; Chipman, P.R.; Kostyuchenko, V.A.; Modrow, S.; Rossmann, M.G. Visualization of the
externalized VP2 N termini of infectious human parvovirus B19. J. Virol. 2008, 82, 7306–7312. [CrossRef]
56. Cotmore, S.F.; Tattersall, P. Genome packaging sense is controlled by the efficiency of the nick site in the
right-end replication origin of parvoviruses minute virus of mice and LuIII. J. Virol. 2005, 79, 2287–2300.
[CrossRef]
57. King, J.A.; Dubielzig, R.; Grimm, D.; Kleinschmidt, J.A. DNA helicase-mediated packaging of
adeno-associated virus type 2 genomes into preformed capsids. EMBO J. 2001, 20, 3282–3291. [CrossRef]
58. Ivanovska, I.; Wuite, G.; Jönsson, B.; Evilevitch, A. Internal DNA pressure modifies stability of WT phage.
Proc. Natl. Acad. Sci. USA 2007, 104, 9603–9608. [CrossRef]
59. Bauer, D.W.; Li, D.; Huffman, J.; Homa, F.L.; Wilson, K.; Leavitt, J.C.; Casjens, S.R.; Baines, J.; Evilevitch, A.
Exploring the Balance between DNA Pressure and Capsid Stability in Herpesviruses and Phages. J. Virol.
2015, 89, 9288–9298. [CrossRef]
60. Shirley, J.A.; Beards, G.M.; Thouless, M.E.; Flewett, T.H. The influence of divalent cations on the stability of
human rotavirus. Arch. Virol. 1981, 67, 1–9. [CrossRef]
61. Sherman, M.B.; Guenther, R.H.; Tama, F.; Sit, T.L.; Brooks, C.L.; Mikhailov, A.M.; Orlova, E.V.; Baker, T.S.;
Lommel, S.A. Removal of divalent cations induces structural transitions in red clover necrotic mosaic virus,
revealing a potential mechanism for RNA release. J. Virol. 2006, 80, 10395–10406. [CrossRef]
62. Plevka, P.; Kazaks, A.; Voronkova, T.; Kotelovica, S.; Dishlers, A.; Liljas, L.; Tars, K. The structure of
bacteriophage phiCb5 reveals a role of the RNA genome and metal ions in particle stability and assembly. J.
Mol. Biol. 2009, 391, 635–647. [CrossRef]
Viruses 2019, 11, 430 21 of 21
63. Llauró, A.; Coppari, E.; Imperatori, F.; Bizzarri, A.R.; Castón, J.R.; Santi, L.; Cannistraro, S.; de Pablo, P.J.
Calcium ions modulate the mechanics of tomato bushy stunt virus. Biophys. J. 2015, 109, 390–397. [CrossRef]
64. Kawano, M.; Xing, L.; Tsukamoto, H.; Inoue, T.; Handa, H.; Cheng, R.H. Calcium Bridge Triggers Capsid
Disassembly in the Cell Entry Process of Simian Virus 40. J. Biol. Chem. 2009, 284, 34703–34712. [CrossRef]
65. Hu, X.; Dong, Q.; Yang, J.; Zhang, Y. Recognizing metal and acid radical ion-binding sites by integrating ab
initio modeling with template-based transferals. Bioinformatics 2016, 32, 3260–3269. [CrossRef]
66. Clapham, D.E. Calcium Signaling. Cell 2007, 131, 1047–1058. [CrossRef]
67. Vihinen-Ranta, M.; Wang, D.; Weichert, W.S.; Parrish, C.R. The VP1 N-terminal sequence of canine parvovirus
affects nuclear transport of capsids and efficient cell infection. J. Virol. 2002, 76, 1884–1891. [CrossRef]
68. Ros, C.; Kempf, C. The ubiquitin–proteasome machinery is essential for nuclear translocation of incoming
minute virus of mice. Virology 2004, 324, 350–360. [CrossRef]
69. Mani, B.; Baltzer, C.; Valle, N.; Almendral, J.M.; Kempf, C.; Ros, C. Low pH-dependent endosomal processing
of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal
sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome. J. Virol. 2006, 80, 1015–1024.
[CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
